ID: ALA4865708

Max Phase: Preclinical

Molecular Formula: C24H27N3O7S

Molecular Weight: 501.56

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1cccc(-n2cc(CO[C@H]3[C@@H](O)[C@@H](CO)O[C@@H](Sc4ccc(C)cc4)[C@@H]3O)nn2)c1

Standard InChI:  InChI=1S/C24H27N3O7S/c1-14-6-8-18(9-7-14)35-24-21(30)22(20(29)19(12-28)34-24)33-13-16-11-27(26-25-16)17-5-3-4-15(10-17)23(31)32-2/h3-11,19-22,24,28-30H,12-13H2,1-2H3/t19-,20+,21-,22+,24+/m1/s1

Standard InChI Key:  UUMOXMMNIFGCGZ-COIJTRFSSA-N

Associated Targets(Human)

Galectin-8 303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-3 545 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 501.56Molecular Weight (Monoisotopic): 501.1570AlogP: 1.48#Rotatable Bonds: 8
Polar Surface Area: 136.16Molecular Species: NEUTRALHBA: 11HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.59CX Basic pKa: CX LogP: 2.47CX LogD: 2.47
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.39Np Likeness Score: -0.53

References

1. Hassan M, van Klaveren S, Håkansson M, Diehl C, Kovačič R, Baussière F, Sundin AP, Dernovšek J, Walse B, Zetterberg F, Leffler H, Anderluh M, Tomašič T, Jakopin Ž, Nilsson UJ..  (2021)  Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation.,  223  [PMID:34225180] [10.1016/j.ejmech.2021.113664]

Source